top of page
18 févr. 2026
Aton Group, a leader in life sciences and medical technology, today announced the appointment of Hadrien Lanvin as Deputy Chief Executive Officer
Illkirch, France, February 18, 2026, - Alumnus of HEC Paris, Hadrien Lanvin is the Founder and CEO of biotechnology firm Evora Biosciences. Having served on Aton's Board of Directors since December 2023, he brings an intimate knowledge of the Group's portfolio and market dynamics. His track record is defined by his expertise in structuring, scaling, and driving value for high-potential scientific assets.
Download ATON press release
bottom of page